Trial intelligence / Profile preview

Inhaled Nitric Oxide for Respiratory Mechanics in TBI

NCT03260569Phase 3Completed

Sponsor
University of Cincinnati
Start
Dec 2018
Primary completion
Dec 2023
Modality
DNA Intercalators/Alkylators, Inhalation Devices
Countries
1
01

Overview

A Phase 3 trial of nitric oxide in traumatic brain injury (TBI), sponsored by University of Cincinnati. Started Dec 2018; status: completed.

02

Drugs

nitric oxide
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on NCT03260569.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03260569.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call